SBIR/STTR Research Award

Development of an innovative approach for in situ treatment of PCB impacted sediments by microbial bioremediation

Award identifier f2523fa69a37952bacc3b986b70f49eb1f206281f5e02bc5d94628bbfecd2beaAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,125,623

Program and phase

SBIR · Phase II

Award year

2023

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
REMBAC ENVIRONMENTAL, LLC
Proposal award date
2023-09-01
Contract end date
2025-07-31
UEI
ESU1JMK4DYJ4
Solicitation number
PA22-176
Topic code
143

Research abstract

PROJECT SUMMARY Polychlorinated biphenyls (PCBs) are one of the most problematic of legacy pollutants. Persistent and mobile in the environment, PCBs are largely ubiquitous in depositional sediments of aquatic systems in industrial regions of the United States. Their relatively high toxicity and bioaccumulation potential cause elevated risk to both human and ecological receptors. As such, PCBs are often the primary risk driver at Superfund sediment sites. Common practices for remediating PCB-impacted sediments are costly, often involving the physical removal of contaminated sediments and disposal of the sediments in a confined landfill, and/or installation of a multi-layered engineered cap over the contaminated sediments. An emerging strategy for effectively removing PCBs from sediments in situ is the use of bio-amended activated carbon (AC), which employs AC pellets inoculated with enriched cultures of PCB-degrading microbes. The co- investigators of this proposed research have performed the fundamental research behind the use of bio- amended AC for remediation of PCBs in sediment and have patented commercially-viable methods for growing, inoculating, and delivering the bioamended AC pellets to sediments. The prior Phase I project, a collaboration between university scientists and RemBac Environmental, addressed two factors that limit the ready use of this technology for large, multi-acre sites: 1) the large-scale growth, storage, and transport of anaerobic PCB degrading bacteria, and; 2) large-scale methods for inoculating and deploying the bioamended AC pellets. The PCB halorespiring anaerobe was successfully scaled up to the maximum density in a bench-scale bioreactor, methods were developed for storage of cells by lyophilization and two approaches were successfully tested for the continuous, uniform inoculation of high volumes of AC pellets with the PCB-degrading microorganisms. The proposed research will advance the technology towards commercialization by demonstrating the efficacy of the methods developed in Phase I for scaled up production at a commercial facility, and perform a pilot-scale demonstration of the technology at the New Bedford Harbor Superfund Site (NBHSS). PCB degrading microorganisms will be scaled up to cell numbers sufficient to treat over 1 acre, and AC pellets will be inoculated on-site using methods developed in Phase I to assess the efficacy of the application methods in a tidal marsh. PCB levels in sediment and water will be assayed after one year to 1) assess the effectiveness and environmental impact of the treatment, and 2) assess the stability of the treatment with tidal activity. Finally, a cost analysis conducted for the entire process to assess the commercial viability of bio-amended AC as a cost- effective treatment for PCB impacted sites. The proposed research is anticipated to result in a direct transfer of this technology from pilot-scale to full commercial viability through an active collaboration with the U.S. Environmental Protection Agency (USEPA), U.S. Army Corps of Engineers (USACE), engineering consultants, and Superfund site stakeholders.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

2 SBIR/STTR records share this UEI (2020–2023). Reported award amounts total $1,265,949. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.